- Current report filing (8-K)

---

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

Date of Report (date of earliest event reported): December 28, 2011

American Oriental Bioengineering, Inc.

(Exact name of registrant as specified in charter)

Nevada

(State or other jurisdiction of incorporation)

001-32569	84-0605867
(Commission File Number)	(IRS Employer Identification No.)

1 Liangshuihe First Ave, Beijing E-Town Economic and Technology Development Area, E-Town,

Beijing, 100176, People’s Republic of China

---

 (Address of principal executive offices and zip code)

 

86-10-5982-2039

---

(Registrant’s telephone number including area code)

---

(Registrant’s former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

---

---

 

 

---

 

Item 5.07  Submission of Matters to a Vote of Security Holders.

 

On December 28, 2011, American Oriental Bioengineering, Inc. (the “Company”) held its annual meeting of stockholders (“Annual Meeting”) to vote on the following matters:

 

1.  Election of Directors

 

All of the following seven nominees were elected to the Company’s Board of Directors, in accordance with the voting results listed below, to serve for a term of one year, until the next Annual Meeting and until their successors have been duly elected and have qualified.

 

Directors		For		Votes Withheld		Broker Non-Votes
Tony Liu		51,640,144		1,727,598		31,646,392
Jun Min		51,691,151		1,676,591		31,646,392
Yanchun Li		50,680,603		2,687,139		31,646,392
Cosimo J. Patti		50,577,162		2,790,580		31,646,392
Xianmin Wang		50,590,190		2,777,552		31,646,392
Lawrence S. Wizel		50,592,509		2,775,233		31,646,392
Baiqing Zhang		51,679,948		1,687,794		31,646,392

 

 

2.  Ratification of the Company’s Independent Auditors

 

The stockholders of the Company ratified the appointment of Ernst & Young Hua Ming as independent auditors to audit the financial statements of the Company for the fiscal year ending December 31, 2011, in accordance with the voting results listed below.

 

For		Votes Against		Abstain
83,779,650		1,144,448		90,036

 

 

2

---

 

3.       Stockholders passed an advisory vote to approve the compensation paid to the Company’s named executive officers.

Votes For		Votes Against		Abstain		Broker Non-Votes
50,157,429		2,883,573		326,740		31,646,392

4.       Stockholders passed an advisory vote directing the Company to seek an advisory vote on the compensation of the Company’s named executive officers each year.

Every One Year		Every Two Years		Every Three Years		Abstain
52,642,281		104,420		175,846		445,195

 

 

 

 

 

 

 

 

 

 

3

---

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	AMERICAN ORIENTAL BIOENGINEERING, INC.
Dated: December 30, 2011	By:   /s/ Tony Liu
	Name: Tony Liu
	Title: Chairman and Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

---